Preclinical activity of PSMA-TTC, a targeted alpha therapeutic in patient-derived prostate cancer models

被引：6
|
作者：
Hammer, Stefanie [1 ]
Hagemann, Urs B. [1 ]
Zitzmann-Kolbe, Sabine [1 ]
Larsen, Aasmund [2 ]
Ellingsen, Christine [2 ]
von Ahsen, Oliver [1 ]
Karlsson, Jenny [2 ]
Bjerke, Roger M. [2 ]
Ryan, Olav B. [2 ]
Lejeune, Pascale [1 ]
Hennekes, Hartwig [1 ]
Cuthbertson, Alan [2 ]
Ziegelbauer, Karl [1 ]
Mumberg, Dominik [1 ]
机构：
[1] Bayer AG, Berlin, Germany
[2] Bayer AS, Oslo, Norway
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-844
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
844
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preclinical pharmacology of the PSMA-targeted thorium-227 conjugate PSMA-TTC: a novel targeted alpha therapeutic for the treatment of prostate cancer
    Hammer, Stefanie
    Larssen, Aasmund
    Ellingsen, Christine
    Geraudie, Solene
    Grant, Derek
    Indrevoll, Baard
    von Ahsen, Oliver
    Kristian, Alexander
    Hagemann, Urs B.
    Karlsson, Jenny
    Bjerke, Roger M.
    Ryan, Olav B.
    Mumberg, Dominik
    Kreft, Bertolt
    Cuthbertson, Alan
    CANCER RESEARCH, 2017, 77
  • [2] Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
    Hammer, Stefanie
    Hagemann, Urs B.
    Zitzmann-Kolbe, Sabine
    Larsen, Aasmund
    Ellingsen, Christine
    Geraudie, Solene
    Grant, Derek
    Indrevoll, Baard
    Smeets, Roger
    von Ahsen, Oliver
    Kristian, Alexander
    Lejeune, Pascale
    Hennekes, Hartwig
    Karlsson, Jenny
    Bjerke, Roger M.
    Ryan, Olav B.
    Cuthbertson, Alan S.
    Mumberg, Dominik
    CLINICAL CANCER RESEARCH, 2020, 26 (08) : 1985 - 1996
  • [3] Preclinical activity of PSMA-TTC (BAY 2315497) in combination with androgen receptor antagonists in prostate cancer models
    Hammer, Stefanie
    Hagemann, Urs B.
    Zitzmann-Kolbe, Sabine
    Larsen, Aasmund
    Ellingsen, Chrstine
    von Ahsen, Oliver
    Karlsson, Jenny
    Bjerke, Roger M.
    Ryan, Olav B.
    Lejeune, Pascale
    Hennekes, Hartwig
    Cuthbertson, Alan
    Mumberg, Dominik
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Preclinical models of prostate cancer: New patient-derived xenografts for preclinical studies and evaluation of prostate cancer biology
    Nguyen, Holly M.
    Morrissey, Colm
    Nelson, Peter S.
    Zhang, Xiaotun
    Lange, Paul H.
    Vessella, Robert L.
    Corey, Eva
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
    Risbridger, Gail P.
    Toivanen, Roxanne
    Taylor, Renea A.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (08):
  • [6] Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
    Risbridger, Gail P.
    Toivanen, Roxanne
    Taylor, Renea A.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [7] New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
    Rago, Vittoria
    Perri, Anna
    Di Agostino, Silvia
    BIOMEDICINES, 2023, 11 (10)
  • [8] Novel patient-derived preclinical models of liver cancer
    Bresnahan, Erin
    Ramadori, Pierluigi
    Heikenwalder, Mathias
    Zender, Lars
    Lujambio, Amaia
    JOURNAL OF HEPATOLOGY, 2020, 72 (02) : 239 - 249
  • [9] Darolutamide potentiates the antitumor efficacy of a PSMA-targeted thorium-227 conjugate (PSMA-TTC) in a hormone-independent prostate cancer model
    Schatz, Christoph
    Hagemann, Urs
    Zitzmann-Kolbe, Sabine
    Haendler, Bernard
    Hennekes, Hartwig
    Hammer, Stefanie
    Scholz, Arne
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies
    Depreeuw, Jeroen
    Hermans, Els
    Schrauwen, Stefanie
    Annibali, Daniela
    Coenegrachts, Lieve
    Thomas, Debby
    Luyckx, Mathieu
    Gutierrez-Roelens, Ilse
    Debruyne, David
    Konings, Katrien
    Moerman, Philippe
    Vergote, Ignace
    Lambrechts, Diether
    Amant, Frederic
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 118 - 126
12345